Skip to Content

Join the 'High Risk Percutaneous Transluminal Angioplasty' group to help and get support from people like you.

High Risk Percutaneous Transluminal Angioplasty News

Take Meds as Directed to Boost Survival After Heart Procedures

Posted 24 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – Taking medications as prescribed improves outcomes for heart procedure patients, a new study finds. Researchers looked at 973 heart bypass patients and 2,255 patients who underwent angioplasty and stenting to reopen clogged heart arteries. Heart bypass surgery is when surgeons take a piece of blood vessel from somewhere else in the body to bypass a blocked portion of the heart's artery. Angioplasty is performed using a thin catheter that's threaded through the blood vessels to the heart. A balloon on the end of the catheter is inflated to open the narrowed blood vessel. Sometimes a stent (a mesh or wire tube) will be left in the blood vessel to keep it open. Prescribed medications in the study included cholesterol-lowering statins, blood thinners and beta blockers. Follow-up information was collected 12 to 18 months after the heart procedures. Overall, ... Read more

Related support groups: Surgery, Aspirin, Metoprolol, Atenolol, Lipitor, Propranolol, Simvastatin, Crestor, Atorvastatin, Bystolic, Pravastatin, Carvedilol, Bisoprolol, Excedrin, Coreg, Inderal, Sotalol, Zocor, Lovastatin, Toprol-XL

Sleep Apnea Tied to Complications After Angioplasty

Posted 15 Jun 2016 by Drugs.com

WEDNESDAY, June 15, 2016 – Sleep apnea may increase the risk of serious complications in people who have undergone angioplasty to clear blocked heart arteries, researchers say. In angioplasty, also called percutaneous coronary intervention (PCI), blocked heart arteries are re-opened using a thin catheter inserted through the groin or wrist. The new study included 241 patients who underwent angioplasty. Their average age was 64 years, and the patients were followed for about six years. Of those patients, slightly more than half had sleep-disordered breathing, which includes sleep apnea and snoring. Sleep apnea is a common and chronic condition, according to the U.S. National Heart, Lung, and Blood Institute (NHLBI). In sleep apnea, breathing stops or becomes shallow during sleep. Breathing pauses can last from a few seconds to minutes, the NHLBI says. Sleep-disordered breathing was ... Read more

Related support groups: Sleep Disorders, Insomnia, Sleep Apnea, Obstructive Sleep Apnea/Hypopnea Syndrome, High Risk Percutaneous Transluminal Angioplasty

Younger Female Heart Patients More Likely to Need Follow-Up Care

Posted 24 Feb 2016 by Drugs.com

TUESDAY, Feb. 23, 2016 – Women under 50 who've been treated once for heart disease seem to fare worse than similarly treated men, a new report shows. Younger women who'd already had a procedure known as angioplasty to open their heart arteries were significantly more likely to need additional procedures to keep those arteries open and functioning well than men were, the study said. Angioplasty is a procedure in which a tiny balloon is inflated inside an artery to widen the vessel and clear partial blockages. The researchers pointed out that even though young women's arteries appeared to be healthier and less blocked than those of their male counterparts, they were still more likely to need more treatment. "Although women tended to have less heart disease than men, they had generally worse outcomes over one year and five years compared to men," said lead researcher Dr. Robert Wilensky, ... Read more

Related support groups: Heart Disease, Coronary Artery Disease (CAD), Acute Coronary Syndrome, Cardiovascular Risk Reduction, Ischemic Heart Disease, Cardiovascular Conditions and Disorders, Percutaneous Coronary Intervention, Acute Coronary Syndrome - Prophylaxis, Coronary Arteriography, High Risk Percutaneous Transluminal Angioplasty

Arm Artery Access Safer for Angioplasty, Review Finds

Posted 13 Nov 2015 by Drugs.com

FRIDAY, Nov. 12, 2015 – For patients experiencing heart attacks or severe chest pain, it is safer to access blocked vessels through an arm artery rather than a groin artery, a new analysis finds. After reviewing four international trials involving more than 17,000 patients, the Italian researchers found that 27 percent fewer patients died when their vessel-opening angioplasties were performed via the arm artery. And more than 40 percent fewer major bleeding events were recorded in this group when compared to the groin artery group, according to the meta-analysis, published Nov. 10 in the Annals of Internal Medicine. "I was not surprised, as several previous trials and pooled analyses had already suggested that radial [arm] access reduces access site-related major bleeding and that this occurrence may ultimately reduce mortality," said study author Dr. Giuseppe Ando, an assistant ... Read more

Related support groups: Surgery, Diagnosis and Investigation, Vascular Surgery, High Risk Percutaneous Transluminal Angioplasty

Angioplasty May Not Boost Survival for Some Heart Disease Patients

Posted 11 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 11, 2015 – Angioplasty – the procedure used to open narrowed or blocked arteries – doesn't seem to lengthen life for people with stable heart disease and chest pain, a new study finds. After 15 years of follow-up, the study found that people who had angioplasty fared no better than those who had their heart disease treated with medication and lifestyle changes alone. "[Angioplasty and] stenting is effective and improves survival when performed early in the course of a heart attack," said lead researcher Dr. Steven Sedlis, an associate professor of medicine at NYU Medical School in New York City. "But the benefits of routine [angioplasty and] stenting for patients with stable heart disease have been uncertain and highly controversial." During the angioplasty procedure, a small tube may be placed in the blood vessel to keep it open. This is called stenting. Routine ... Read more

Related support groups: Heart Disease, Angina, Coronary Artery Disease (CAD), Angina Pectoris Prophylaxis, Acute Coronary Syndrome, Ischemic Heart Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome - Prophylaxis, Post MI Syndrome, Coronary Arteriography, High Risk Percutaneous Transluminal Angioplasty

1 in 6 Americans Too Far From Lifesaving Heart Centers

Posted 13 Jul 2015 by Drugs.com

MONDAY, July 13, 2015 – Tens of millions of rural, poor and Hispanic Americans do not have timely access to a lifesaving heart procedure, a new study finds. Researchers analyzed the driving times for 306 million people to reach the closest angioplasty centers across the continental United States. Angioplasty is used to open blocked heart arteries. A catheter is used to insert a deflated balloon into the artery. The balloon is then inflated to open the artery and restore blood flow to the heart. There are more than 1,700 angioplasty centers in the United States, the researchers said. The median time to an angioplasty center was 33 minutes, they found. However, the median travel time for more than 16 percent of the population – about 50 million people – was 81 minutes, according to the study. Results were published July 13 in the journal Health Services Research. It shouldn't take ... Read more

Related support groups: Coronary Artery Disease (CAD), Peripheral Arterial Disease, Acute Coronary Syndrome, Percutaneous Coronary Intervention, Acute Coronary Syndrome - Prophylaxis, High Risk Percutaneous Transluminal Angioplasty, Coronary Arteriography

Anti-Clotting Drug Approved For Angioplasty

Posted 22 Jun 2015 by Drugs.com

MONDAY, June 22, 2015 – Kengreal (cangrelor) has been approved by the U.S. Food and Drug Administration to prevent blood clots from forming during angioplasty. Angioplasty involves inflating a balloon inside a clogged artery to improve blood flow. This is typically followed by insertion of a stent, a small mesh tube designed to keep the artery open. Some 500,000 people in the United States have the procedure – medically called percutaneous coronary intervention – annually, the FDA said in a news release. Formation of a blood clot during the procedure could lead to heart attack. As with any anti-clotting drug, life-threatening bleeding is a potential side effect, the agency noted. In clinical trials, Kengreal was compared to the anti-clotting drug Plavix (clopidogrel) among more than 10,000 participants. Cases of serious bleeding, while still rare, were more common among users who ... Read more

Related support groups: Magnetic Resonance Angiography, High Risk Percutaneous Transluminal Angioplasty, Digital Subtraction Angiography, Cangrelor, Intra-arterial Digital Subtraction Angiography, Peripheral Angiography, Kengreal

Quitting Smoking Improves Angioplasty Outcome, Study Finds

Posted 12 May 2015 by Drugs.com

TUESDAY, May 12, 2015 – Patients who quit smoking when they have angioplasty – a heart blood vessel-opening procedure – have better outcomes, a new study finds. Quitting smoking was associated with less chest pain and better quality of life, researchers reported. "It's a no-brainer. Stopping smoking seems like a relatively easy way to increase your chances of getting the best outcomes from angioplasty," said senior author and cardiologist Dr. John Spertus, clinical director of outcomes research at Saint Luke's Mid America Heart Institute in Kansas City. The researchers followed more than 2,700 adults who underwent angioplasty for either a heart attack or chest pain. One year after the procedure, 21 percent of those who quit smoking when they had angioplasty had chest pain, compared with 31 percent of those who kept smoking, and 19 percent of those who never smoked or quit smoking ... Read more

Related support groups: Smoking, Heart Attack, Smoking Cessation, Myocardial Infarction, Cardiovascular Risk Reduction, Magnetic Resonance Angiography, Diagnosis and Investigation, Myocardial Infarction - Prophylaxis, High Risk Percutaneous Transluminal Angioplasty, Angiocardiography, Intravenous Digital Subtraction Angiography, Peripheral Angiography, Digital Subtraction Angiography, Intra-arterial Digital Subtraction Angiography

Manual Clot Removal After Heart Attack May Not Help, Could Harm

Posted 16 Mar 2015 by Drugs.com

MONDAY, March 16, 2015 – A new study calls into question the value of removing blood clots from a patient's heart arteries during angioplasty, a procedure to open blocked arteries. Although manually removing clots has become common medical practice, this study of more than 10,000 heart attack patients found no benefit in terms of reducing death, heart attack or heart failure in the six months after the procedure. Removing clots appears to have increased the risk of stroke in the month after clots were removed, the Canadian researchers report. "There has been some controversy about removing blood clots during the treatment of heart attacks," said lead researcher Dr. Sanjit Jolly, an associate professor of cardiology at McMaster University in Hamilton, Ontario. A study in 2008 suggested that removing clots during an angioplasty might save lives, he said. "Guidelines changed based on this ... Read more

Related support groups: Heart Attack, Myocardial Infarction, Diagnosis and Investigation, Percutaneous Coronary Intervention, High Risk Percutaneous Transluminal Angioplasty

Plavix Can Help Cut Death Risk in Certain Heart Patients

Posted 22 Mar 2010 by Drugs.com

MONDAY, March 22 – The anti-clotting drug Plavix is of modest benefit in cutting the odds of death in patients with heart failure and heart attack who don't undergo angioplasty, a new study finds. Angioplasty is a procedure to open blocked arteries. Danish researchers analyzed data from more than 31,000 patients hospitalized with heart attack between 2000 and 2005 and divided the patients into four groups: two groups with heart failure (one that received Plavix and one that did not) and two groups without heart failure (one that received Plavix and one that did not). The mean follow-up was 18 months for both heart failure groups and just over two years for both non-heart failure groups. There were 812 deaths (32.2 percent) among heart failure patients not treated with Plavix and 709 deaths (28.1 percent) among heart failure patients treated with Plavix. There were 294 deaths (9.7 ... Read more

Related support groups: Plavix, High Risk Percutaneous Transluminal Angioplasty

Ask a Question

Further Information

Related Condition Support Groups

Percutaneous Coronary Intervention

Related Drug Support Groups

allopurinol, ReoPro, abciximab